GlycoMimetics, Inc. (NASDAQ:GLYC) is in a rising channel and finally broke out two days ago, consolidated for a couple days, had an inside day on Tuesday, and on Wednesday, it popped 1.11, or 5.87%, to 20.03, on 532,425 shares traded. The volume wasn’t great, but the OBV is looking good. If it extends, I’m looking for 22 1/2-3/4 as the next target, and then 26.
Remark Holdings, Inc. (NASDAQ:MARK) ran 1.01, or 7.69, to 14.15, on 2.3 million shares traded on Wednesday. It had an inside day on Tuesday that held really nicely. It popped after reversing off the pullback low, and closed at the highest level in the last couple years. Technicals look good. My swing target of 15 may be met Thursday morning, and then the intermediate target is 20.
Mirati Therapeutics, Inc. (NASDAQ:MRTX) jumped 2.70, or 14%, to 21.75, on 619,710 shares traded on Wednesday. Its swing from Sept continues to channel up. It stalled in the last five or six weeks, and broke out on Wednesday. The volume wasn’t real heavy, but it did pick up the best in a couple weeks, and closed at the highs for the day going away. I think it’s going to hit 24-5.
Pain Therapeutics, Inc. (NASDAQ:PTIE) exploded, pulled back, we had a nice trade recommendation on it right at the 7.85 area, and it closed at 9.22, up 18 cents, or 2%, on 3.7 million shares traded. My targets on this one are 13-13 1/2, and then maybe it will get moving to the 20-1 range.
On the long side, stocks included Biomerica, Inc. (NASDAQ:BMRA), Cloudera, Inc. (NYSE:CLDR), Cheetah Mobile Inc. (NYSE:CMCM), Collegium Pharmaceutical, Inc. (NASDAQ:COLL), Corcept Therapeutics Incorporated (NASDAQ:CORT), Digital Power Corporation (NYSE:DPW), Emerge Energy Services (NYSE:EMES), Amicus Therapeutics, Inc. (NASDAQ:FOLD), Global Blood Therapeutics, Inc. (NASDAQ:GBT), GlycoMimetics, Inc. (NASDAQ:GLYC), Helios and Matheson Analytics Inc. (NASDAQ:HMNY), Direxion Daily S&P Biotech Bull 3X ETF (NYSE:LABU), Remark Holdings, Inc. (MARK), Mirati Therapeutics, Inc. (MRTX), Novavax, Inc. (NASDAQ:NVAX), Pain Therapeutics, Inc. (NASDAQ:PTIE), SM Energy Company (NYSE:SM), TransAct Technologies Incorporated (NASDAQ:TACT), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Vuzix Corporation (NASDAQ:VUZI), and Energous Corporation (NASDAQ:WATT).